Atlas Trials

Thrombosis, Venous

18 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Thrombosis, Venous

RecordFirmDate
Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective Study (NCT05396157)Mount Sinai Hospital, Canada2021-11-01
Catheter Associated Asymptomatic Thrombosis in Intensive Care Unit (NCT04503135)Policlinico Hospital2020-09-01
Recurrence and Bleeding in Colorectal Cancer Patients With Cancer-associated Venous Thrombembolism (NCT06440044)Sixth Affiliated Hospital, Sun Yat-sen University2019-01-01
ARIXTRA® Adherence in SVT Patients. (NCT01691495)GlaxoSmithKline2012-10-01
Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery (NCT01444612)GlaxoSmithKline2010-02-01
Hemorrhage Risk Prescribed Arixtra (NCT01064362)GlaxoSmithKline2010-01-01
A Study to Evaluate the Efficacy and Safety of Fondaparinux for the Prevention of Venous Blood Clots in Patients With a Plaster Cast or Other Type of Immobilization for a Below-knee Injury Not Needing Surgery (NCT00843492)GlaxoSmithKline2008-12-01
The Treatment of Acute Deep Vein Thrombosis (DVT) of GSK576428 (Fondaparinux Sodium) in Japanese Patients (NCT00911157)GlaxoSmithKline2008-06-01
Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis) (NCT00443053)GlaxoSmithKline2007-03-01
Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer (NCT00312013)GlaxoSmithKline2006-05-01
Total Hip Replacement Study Of GSK576428 (Fondaparinux Sodium) (NCT00320398)GlaxoSmithKline2006-01-30

Track Thrombosis, Venous automatically

Every clearance here is in the API, with alerts when new ones post.